Metformin, SGLT2is Link With Longer T2D Survival Metformin, SGLT2is Link With Longer T2D Survival

Treatment with metformin or an agent from the SGLT2 inhibitor class linked with significantly better survival in people with type 2 diabetes in UK Biobank data.First Look

Source: Medscape Pulmonary Medicine Headlines - June 12, 2023 Category: Respiratory Medicine Tags: Diabetes & Endocrinology News Source Type: news